Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dacomitinib only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dacomitinib in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib 15 mg oral tablet |
Has precise active ingredient |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib monohydrate |
Is modification of (attribute) |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dacomitinib 30 mg oral tablet |
Has precise active ingredient |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib 30 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib 45 mg oral tablet |
Has precise active ingredient |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib 45 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dacomitinib anhydrous (substance) |
Is modification of (attribute) |
True |
Dacomitinib (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|